The Competition Commission of India (CCI) has granted approval for the acquisition by Integrace Private Limited of share capital in Universal Nutriscience Private Limited along with certain related transactions. This proposed combination involves Integrace acquiring share capital of Universal Nutriscience from its existing shareholders.
Integrace Private Limited is described as an orthopaedics and gynaecology-focused domestic formulations company with a portfolio of over 20 products catering to pain management, pregnancy, and women's health. The company maintains a specialist coverage base of healthcare professionals across orthopaedics and gynaecology specialties. Integrace operates as a subsidiary of Morning Waves Investments B.V., which is in turn an affiliate of Warburg Pincus LLC and/or its affiliates. Morning Waves Investments currently holds shareholding only in Integrace and functions as a holding company.
Universal Nutriscience Private Limited is characterized as a nutraceutical company focused on nutraceutical and lifestyle products. The company has expressed intentions to develop new products and novel drug delivery systems as part of its business strategy.
The approval was officially posted on October 22, 2026, at 8:26 PM by PIB Delhi, with release ID 2326894.